Notably, combining CEA or CA199, the canonical plasma-based CRC biomarkers, with SNORA56 markedly increased their AUC values (Fig. 6E–F), implying improved diagnostic value. This evidence concerns the gene CEACAM5 and colorectal carcinoma.